Two vaccine candidates set to join DR Congo Ebola trial
WHO plans to add ChAdOx1 and mRNA-1469 to the DR Congo Bundibugyo Ebola trial following national approvals.
Original source ↗Ebola candidates await approvals for trial entry. Water disruption undermines infection control and care. Nepal faces recovery needs and Dominican equipment requires sustained operation.
WHO plans to add ChAdOx1 and mRNA-1469 to the DR Congo Bundibugyo Ebola trial following national approvals.
Original source ↗UNICEF reported that attacks on water and sanitation rose from fewer than 45 in 2021 to over 135 in 2025. Its study covers January 2021–June 2026.
Original source ↗The UN reported on 5 November that August floods damaged homes, power grids and 115 bridges. Estimated recovery costs are $4.7 billion.
Original source ↗The SNS announced operation of a laparoscopic unit at Alejandro Cabral hospital on 5 November, within more than RD15 million of regional equipment and facility investment.
Original source ↗